These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 22892768

  • 1. Clinical, epidemiological and mycological report on 65 patients from the Eastern Amazon region with chromoblastomycosis.
    Pires CA, Xavier MB, Quaresma JA, Macedo GM, Sousa BR, Brito AC.
    An Bras Dermatol; 2012; 87(4):555-60. PubMed ID: 22892768
    [Abstract] [Full Text] [Related]

  • 2. Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region.
    Avelar-Pires C, Simoes-Quaresma JA, Moraes-de Macedo GM, Brasil-Xavier M, Cardoso-de Brito A.
    Arch Med Res; 2013 May; 44(4):302-6. PubMed ID: 23684532
    [Abstract] [Full Text] [Related]

  • 3. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS, de Almeida AMZ, Basano SA, Takagi EH, Szeszs MW, Melhem MSC, Albuquerque M, Camargo JSAA, Gambale W, Camargo LMA.
    Med Mycol; 2020 Feb 01; 58(2):172-180. PubMed ID: 31329924
    [Abstract] [Full Text] [Related]

  • 4. Clinical and demographic profile of chromoblastomycosis in a referral service in the midwest of São Paulo state (Brazil).
    Marques GF, Masuda PY, Sousa JM, Barreto JA, Wachholz PA.
    An Bras Dermatol; 2015 Feb 01; 90(1):140-2. PubMed ID: 25672318
    [Abstract] [Full Text] [Related]

  • 5. Chromoblastomycosis: a clinical and molecular study of 18 cases in Rio de Janeiro, Brazil.
    Mouchalouat Mde F, Gutierrez Galhardo MC, Zancopé-Oliveira RM, Monteiro Fialho PC, de Oliveira Coelho JM, Silva Tavares PM, Francesconi do Valle AC.
    Int J Dermatol; 2011 Aug 01; 50(8):981-6. PubMed ID: 21781072
    [Abstract] [Full Text] [Related]

  • 6. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil).
    Silva JP, de Souza W, Rozental S.
    Mycopathologia; 2011 Aug 01; 143(3):171-5. PubMed ID: 10353215
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle.
    Khan S, Kumar A, Vinod V, Prabhakar V, Eapen M, Thomas J, Dinesh K, Karim S.
    J Infect Dev Ctries; 2015 Mar 15; 9(3):325-9. PubMed ID: 25771474
    [Abstract] [Full Text] [Related]

  • 10. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
    Fransisca C, He Y, Chen Z, Liu H, Xi L.
    Med Mycol; 2017 Nov 01; 55(8):851-858. PubMed ID: 28053146
    [Abstract] [Full Text] [Related]

  • 11. Molecular Epidemiology of Agents of Human Chromoblastomycosis in Brazil with the Description of Two Novel Species.
    Gomes RR, Vicente VA, Azevedo CM, Salgado CG, da Silva MB, Queiroz-Telles F, Marques SG, Santos DW, de Andrade TS, Takagi EH, Cruz KS, Fornari G, Hahn RC, Scroferneker ML, Caligine RB, Ramirez-Castrillon M, de Araújo DP, Heidrich D, Colombo AL, de Hoog GS.
    PLoS Negl Trop Dis; 2016 Nov 01; 10(11):e0005102. PubMed ID: 27893750
    [Abstract] [Full Text] [Related]

  • 12. [Fonsecaea pedrosoi-induced chromoblastomycosis: about a case].
    Baline K, Hali F.
    Pan Afr Med J; 2018 Nov 01; 30():187. PubMed ID: 30455816
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A.
    Med Mycol; 2009 Feb 01; 47(1):3-15. PubMed ID: 19085206
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
    Guevara A, Nery AF, de Souza Carvalho Melhem M, Bonfietti L, Rodrigues AM, Hagen F, de Carvalho JA, de Camargo ZP, de Souza Lima BJF, Vicente VA, Hahn RC.
    Mycoses; 2022 Dec 01; 65(12):1146-1158. PubMed ID: 35869803
    [Abstract] [Full Text] [Related]

  • 18. Chromoblastomycosis in India: Review of 169 cases.
    Agarwal R, Singh G, Ghosh A, Verma KK, Pandey M, Xess I.
    PLoS Negl Trop Dis; 2017 Aug 01; 11(8):e0005534. PubMed ID: 28771470
    [Abstract] [Full Text] [Related]

  • 19. Squamous cell carcinoma derived from chronic chromoblastomycosis in Brazil.
    Azevedo CM, Marques SG, Santos DW, Silva RR, Silva NF, Santos DA, Resende-Stoianoff MA.
    Clin Infect Dis; 2015 May 15; 60(10):1500-4. PubMed ID: 25681378
    [Abstract] [Full Text] [Related]

  • 20. Mixed secondary bacterial infection is associated with severe lesions of chromoblastomycosis in a neglected population from Brazil.
    Marques SG, Bomfim MRQ, Azevedo CMPS, Martins CVB, Marques ACG, Gonçalves AG, Vicente VA, Dos Santos AM, Costa MC, Freitas GJC, Santos DA, de Resende-Stoianoff MA.
    Diagn Microbiol Infect Dis; 2019 Oct 15; 95(2):201-207. PubMed ID: 31262546
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.